Councils - Pulmonary Transplantation



Scientific Council on Pulmonary Transplantation



NOT A COUNCIL MEMBER?

Council membership is open to all ISHLT members. Joining is easy. Simply login to the ISHLT Members Only Website where you can update your membership profile and join any of the 12 Scientific Councils.



CALL FOR COUNCIL VICE CHAIR NOMINATIONS

NOMINATION FORM


PAST COUNCIL MEETING:
Thursday, April 6, 2017, 12:30 PM - 2:00 PM
in Grand Hall C of the Manchester Grand Hyatt Hotel, San Diego, CA, USA, during the ISHLT 37th Annual Meeting and Scientific Sessions



APPROVED CORE COMPETENCY CURRICULUM DOCUMENT:

Pulmonary Transplantation (PDF)



HEALTH-RELATED QUALITY OF LIFE (HRQL) RESOURCES:

The resources below were developed by the ISHLT Pulmonary Transplantation Council QOL Workforce for clinicians and investigators alike. These resources aim to provide organized, up-to-date summaries of information focused on HRQL in lung transplantation.

HRQL AND LUNG TRANSPLANTATION:
An Annotated Bibliography PDF (2017 Update)

This annotated bibliography of peer-reviewed publications focused on HRQL in lung transplantation is organized by theme including:

I. Determinants of HRQL
II. Psychosocial factors in HRQL
III. Comparisons of HRQL before and after lung transplantation
IV. Long-term longitudinal studies of HRQL in lung transplant recipients
V. The effect of therapies and interventions on HRQL
VI. Instrument validation and methodology
VII. HRQL as a predictor of clinical outcomes
VIII.  Reviews and Editorials

ISHLT Instruments Used to Measure HRQL in Lung Transplantation PDF (2017 Update)
This table is an organized list of the HRQL, health status and utility instruments used in studies examining HRQL in lung transplantation.  In addition, links to the original manuscript that introduced each instrument and to the instrument webpage (if available) are provided.

ISHLT Targeted Additional HRQL Resources PDF (2017 Update)
If you are aware of new articles or resources that are missing, please email jon.singer@ucsf.edu.



LINKS NEWSLETTER:

Issues focusing on Pulmonary Transplantation

March 2017
January 2017
August 2016
March 2016
March 2016
October 2015
March 2015
August 2014
February 2014
October 2013
May 2013 - PULM TX Council Year in Review
February 2013
November 2011 (PDF)




OTHER LINKS:
  • 07-26-2017 Operating Board Conference Call Minutes (PDF)
  • Lung Transplantation Core Competency Curriculum (ISHLT LTx CCC) PDF
  • DCD Guidelines PDF


COUNCIL LEADERSHIP OPERATING BOARD
(Parentheses after name indicates year rotating off Board)


COUNCIL CHAIR:

Cynthia J. Gries, MD, MSc (2020)
Florida Hospital
Orlando, FL, USA

Dr. Cynthia Gries is the Medical Director of the Lung Transplant Program at Florida Hospital in Orlando, Florida. Dr. Gries attended medical school at the University of Chicago in Chicago, IL. She completed her internal medicine residency at Johns Hopkins University in Baltimore, MD and completed her fellowship at the University of Washington in Seattle, WA. She subsequently completed her masters in Epidemiology at the University of Washington. Dr. Gries is involved in research with her main focus being on improving the long-term outcomes in lung transplant patients. She is an international speaker regarding recipient selection and the lung allocation process.



COUNCIL VICE CHAIR:

Ramsey R. Hachem, MD (2022)
Washington University School of Medicine
Barnes Jewish Hospital
St. Louis, MO, USA

Dr. Hachem completed training in Internal Medicine at the University of Texas Southwestern Medical Center in Dallas then completed training in Pulmonary & Critical Care at Washington University in St. Louis School of Medicine.  He is currently the Tracey C. Marshall – Dr. Elbert P. Trulock Distinguished Professor of Medicine at Washington University in St. Louis School of Medicine.  He is the Medical Director of the Lung Transplant Program at Washington University and Barnes-Jewish Hospital.  His research interests include the role of humoral immunity in allograft rejection and the management of chronic lung allograft dysfunction.



COUNCIL PAST CHAIR:

Michael Mulligan, MD (2018)
University of Washington School of Medicine
Seattle, Washington, USA

Dr. Michael S. Mulligan is an Endowed Professor in Lung Transplant Research, Chief of the Thoracic Surgery Section, Director of the Lung Transplant Program and Minimally Invasive Surgery Program as well as Director of the Cardiothoracic Research Laboratory at the University of Washington, Seattle, Washington, and one of the only surgeons in the Pacific Northwest who performs pulmonary endarterectomies for chronic pulmonary embolic disease. He organizes national courses in VATS lobectomy and critical care, and lectures internationally on lung transplantation and lung donor management. His laboratory has been consistently funded by the NIH and investigates mechanisms involved in acute lung transplant dysfunction. Dr. Mulligan attended medical school at the University of Connecticut. He completed his general surgery residency at Columbia Presbyterian in Noew York, NY and took time out during his residency for a two-year post doctoral research fellowship in the laboratory of Dr. Peter Ward at the University of Michigan in Ann Arbor, Michigan. He subsequently completed a heart and lung transplant fellowship at the University of Michigan, followed by a cardiothoracic residency at the University of Michigan and finally a general thoracic fellowship, also at the University of Michigan. During that final year in Ann Arbor, he traveled to San Diego to further study the diagnosis and treatment of Chronic Thromboembolic Hypertension.



BOARD OF DIRECTORS LIAISON:

Peter M. Hopkins, FRACP (2018)
The Prince Charles Hospital
Brisbane, AUSTRALIA

Dr Peter Hopkins is the Director of the Queensland Lung Transplant Service and Associate Professor with the School of Medicine, University of Queensland, Brisbane. Research interests include First in Man clinical trials of innovative bronchoscopic techniques of lung volume reduction and development of novel treatment strategies for interstitial lung disease. executive positions are held with the Australian Lung Foundation (PIVOR and the Australian IPF Registry), Deputy Chair of the Lung Standing Committee Transplant Society of Australia and New Zealand, Convenor SIG Interventional Bronchoscopy Thoracic Society of Australia and New Zealand and national Examiners Panel Royal Australian College of Physicians.



EDUCATION WORKFORCE LEADER:

Lorriana E. Leard, MD (2018)
University of California, San Francisco
San Francisco, CA, USA

Lorriana Leard, MD is an Associate Professor of Clinical Medicine at the University of California San Francisco where she is the Chief of Clinical Operations for the Division of Pulmonary, Critical Care, Allergy and Sleep Medicine and the Associate Program Director for the Pulmonary and Critical Care Fellowship Program. Her primary interests are in medical education and lung transplantation. Dr. Leard received her undergraduate degree from Stanford University and her M.D. from the University of California San Diego. After completing her Internal Medicine residency at the University of Texas Southwestern in Dallas, she came to the University of California San Francisco for her Pulmonary and Critical Care Fellowship. She completed an additional subspecialty fellowship in Lung Transplantation at the University of California San Francisco.



I2C2 WORKFORCE LEADER:

Denis Hadjiliadis, MD (2019)
University of Pennsylvania
Philadephia, PA, USA

Denis Hadjiliadis, MD, did his undergraduate studies at McGill University and completed his medical degree at the University of Toronto in 1995. He subsequently pursued training in Internal Medicine at the Mayo Clinic and Pulmonary and Critical Care at Duke University, where he also completed a Master’s of Health Sciences in 2001. He joined the faculty at the University of Toronto in 2001, after further training in Lung Transplantation and Cystic Fibrosis. He joined the University of Pennsylvania in 2005 and has been the Adult Program Director of the Cystic Fibrosis Program since 2009, while remaining active at the Penn Lung Transplant Program. He is currently the Paul F. Harron Jr. Associate Professor of Medicine, at the Perelman School of Medicine of the University of Pennsylvania.




STANDARDS AND GUIDELINES COMMITTEE WORKFORCE LEADER:

Erika D. Lease, MD (2020)
University of Washington
Seattle, WA, USA

Erika Lease, MD, is the Medical Director of the Lung Transplant Program at the University of Washington in Seattle, Washington, and an Associate Professor within the Division of Pulmonary, Critical Care, and Sleep Medicine. She also attends on the Solid Organ Transplant Infectious Disease service. Dr. Lease earned her undergraduate degrees and medical degree from the University of Washington in Seattle, Washington. She then completed residency training in Internal Medicine and Pediatrics at Duke University, in Durham, North Carolina, where she stayed to complete fellowship training in Pulmonary and Critical Care Medicine as well as Infectious Disease.



QUALITY OF LIFE WORKFORCE LEADER:

Jonathan P Singer, MD, MS
UC San Francisco
San Francisco, CA, USA

Dr. Jonathan Singer is a transplant pulmonologist and Assistant Professor of Medicine in the Division of Pulmonary, Critical Care, Allergy and Sleep Medicine at the University of California, San Francisco.  At UCSF, he is the Associate Medical Director of Lung Transplant Outcomes Research and is a core investigator with the UCSF Respiratory Epidemiology Group. His research focuses broadly on how lung transplantation improves patient-centered outcomes including functioning, disability, health-related quality of life, and survival. An area of particular interest is how frailty and refined assessments of body composition impact patient-centered outcomes in lung transplant candidates and recipients.

Dr. Singer received his undergraduate degree from Stanford University and a Masters in Health and Medical Sciences from the School of Public Health at UC Berkeley. He moved to UCSF to complete his medical degree, residency in internal medicine, and fellowships in pulmonary, critical care, and lung transplantation.




LINKS NEWSLETTER LIAISON:

Jussi Tikkanen, MD, PhD
University Health Network
Toronto, ON, CANADA

Jussi Tikkanen is originally from Helsinki, Finland but currently works as a lung transplant physician in the Toronto Lung Transplant Program. His research interests include donor-specific antibodies, primary graft dysfunction, and chronic lung allograft dysfunction.




LIAISONS TO OTHER COUNCILS:

BSTR COUNCIL LIAISON:

Pablo G. Sanchez, MD, PhD (2020)
University of Pittsburgh
Pittsburgh, PA, USA

Pablo G Sanchez, MD PhD, is a Lung Transplant Surgeon. He is the  Associate Director of Lung Transplant and the Adult ECLS program and the Director of Ex vivo Lung Perfusion and Lung Transplant Research at the University of Pittsbugh. He obtained his MD from the University of Cordoba, Argentina in 1999. Residency and Thoracic Surgery fellowship was obtained at the Santa Casa de Misericordia, Porto Alegre, Brazil. He also completed a research fellowship at the University of Pennsylvania, and a Post Doc fellowship at the University of Maryland. He is a national co-investigator for the NOVEL trial, evaluating the use of ex vivo perfusion to increase lung donor use. He received the F. Griffith Pearson Fellowship from The American Association for Thoracic Surgery. He has also received funding from the Maryland Stem Cell Research Foundation, the ISHLT research fellowship award and the University of Maryland and Living Legacy Foundation Transplantation Grant Program Award.



JFTC COUNCIL LIAISON:

Joshua J Mooney, MD (2019)
Stanford University
Stanford, CA, USA

Dr. Joshua Mooney is a Clinical Assistant Professor at Stanford University who specializes in the care of interstitial lung disease and lung transplant patients. He received his medical degree at University of Minnesota and then completed Internal Medicine residency at the University of California San Francisco followed by Pulmonary and Critical Care Fellowship and a Masters degree in Health Services Research at Stanford University. He performs health services and outcomes research focused on improving the lives and care of patients with advanced lung disease and is actively involved in clinical trials to improve outcomes in interstitial lung disease.



NHSAH COUNCIL LIAISON:

Nicole Davis, BSN, MPH, CCTC
Tampa General Hospital
Tampa, FL, USA

Nicole Davis has been a lung transplant coordinator at Tampa General Hospital for the past 3 years. Prior to that she worked as a transplant nurse clinician for 5 years. She received her BSN and MPH from East Carolina University. Her focus is currently on process improvement within the pre and post lung transplant clinics at Tampa General Hospital.


COUNCIL LEADERSHIP OPERATING BOARD
(Parentheses after name indicates year rotating off Board)


COUNCIL CHAIR:

Cynthia J. Gries, MD, MSc (2020)
Florida Hospital
Orlando, FL, USA

Dr. Cynthia Gries is the Medical Director of the Lung Transplant Program at Florida Hospital in Orlando, Florida. Dr. Gries attended medical school at the University of Chicago in Chicago, IL. She completed her internal medicine residency at Johns Hopkins University in Baltimore, MD and completed her fellowship at the University of Washington in Seattle, WA. She subsequently completed her masters in Epidemiology at the University of Washington. Dr. Gries is involved in research with her main focus being on improving the long-term outcomes in lung transplant patients. She is an international speaker regarding recipient selection and the lung allocation process.


COUNCIL VICE CHAIR:

Ramsey R. Hachem, MD (2022)
Washington University School of Medicine
Barnes Jewish Hospital
St. Louis, MO, USA

Dr. Hachem completed training in Internal Medicine at the University of Texas Southwestern Medical Center in Dallas then completed training in Pulmonary & Critical Care at Washington University in St. Louis School of Medicine.  He is currently the Tracey C. Marshall – Dr. Elbert P. Trulock Distinguished Professor of Medicine at Washington University in St. Louis School of Medicine.  He is the Medical Director of the Lung Transplant Program at Washington University and Barnes-Jewish Hospital.  His research interests include the role of humoral immunity in allograft rejection and the management of chronic lung allograft dysfunction.


COUNCIL PAST CHAIR:

Michael Mulligan, MD (2018)
University of Washington School of Medicine
Seattle, Washington, USA

Dr. Michael S. Mulligan is an Endowed Professor in Lung Transplant Research, Chief of the Thoracic Surgery Section, Director of the Lung Transplant Program and Minimally Invasive Surgery Program as well as Director of the Cardiothoracic Research Laboratory at the University of Washington, Seattle, Washington, and one of the only surgeons in the Pacific Northwest who performs pulmonary endarterectomies for chronic pulmonary embolic disease. He organizes national courses in VATS lobectomy and critical care, and lectures internationally on lung transplantation and lung donor management. His laboratory has been consistently funded by the NIH and investigates mechanisms involved in acute lung transplant dysfunction. Dr. Mulligan attended medical school at the University of Connecticut. He completed his general surgery residency at Columbia Presbyterian in Noew York, NY and took time out during his residency for a two-year post doctoral research fellowship in the laboratory of Dr. Peter Ward at the University of Michigan in Ann Arbor, Michigan. He subsequently completed a heart and lung transplant fellowship at the University of Michigan, followed by a cardiothoracic residency at the University of Michigan and finally a general thoracic fellowship, also at the University of Michigan. During that final year in Ann Arbor, he traveled to San Diego to further study the diagnosis and treatment of Chronic Thromboembolic Hypertension.


BOARD OF DIRECTORS LIAISON:

Peter M. Hopkins, FRACP (2018)
The Prince Charles Hospital
Brisbane, AUSTRALIA

Dr Peter Hopkins is the Director of the Queensland Lung Transplant Service and Associate Professor with the School of Medicine, University of Queensland, Brisbane. Research interests include First in Man clinical trials of innovative bronchoscopic techniques of lung volume reduction and development of novel treatment strategies for interstitial lung disease. executive positions are held with the Australian Lung Foundation (PIVOR and the Australian IPF Registry), Deputy Chair of the Lung Standing Committee Transplant Society of Australia and New Zealand, Convenor SIG Interventional Bronchoscopy Thoracic Society of Australia and New Zealand and national Examiners Panel Royal Australian College of Physicians.


EDUCATION WORKFORCE LEADER:

Lorriana E. Leard, MD (2018)
University of California, San Francisco
San Francisco, CA, USA

Lorriana Leard, MD is an Associate Professor of Clinical Medicine at the University of California San Francisco where she is the Chief of Clinical Operations for the Division of Pulmonary, Critical Care, Allergy and Sleep Medicine and the Associate Program Director for the Pulmonary and Critical Care Fellowship Program. Her primary interests are in medical education and lung transplantation. Dr. Leard received her undergraduate degree from Stanford University and her M.D. from the University of California San Diego. After completing her Internal Medicine residency at the University of Texas Southwestern in Dallas, she came to the University of California San Francisco for her Pulmonary and Critical Care Fellowship. She completed an additional subspecialty fellowship in Lung Transplantation at the University of California San Francisco.


I2C2 WORKFORCE LEADER:

Denis Hadjiliadis, MD (2019)
University of Pennsylvania
Philadephia, PA, USA

Denis Hadjiliadis, MD, did his undergraduate studies at McGill University and completed his medical degree at the University of Toronto in 1995. He subsequently pursued training in Internal Medicine at the Mayo Clinic and Pulmonary and Critical Care at Duke University, where he also completed a Master’s of Health Sciences in 2001. He joined the faculty at the University of Toronto in 2001, after further training in Lung Transplantation and Cystic Fibrosis. He joined the University of Pennsylvania in 2005 and has been the Adult Program Director of the Cystic Fibrosis Program since 2009, while remaining active at the Penn Lung Transplant Program. He is currently the Paul F. Harron Jr. Associate Professor of Medicine, at the Perelman School of Medicine of the University of Pennsylvania.


STANDARDS AND GUIDELINES COMMITTEE WORKFORCE LEADER:

Erika D. Lease, MD (2020)
University of Washington
Seattle, WA, USA

Erika Lease, MD, is the Medical Director of the Lung Transplant Program at the University of Washington in Seattle, Washington, and an Associate Professor within the Division of Pulmonary, Critical Care, and Sleep Medicine. She also attends on the Solid Organ Transplant Infectious Disease service. Dr. Lease earned her undergraduate degrees and medical degree from the University of Washington in Seattle, Washington. She then completed residency training in Internal Medicine and Pediatrics at Duke University, in Durham, North Carolina, where she stayed to complete fellowship training in Pulmonary and Critical Care Medicine as well as Infectious Disease.


QUALITY OF LIFE WORKFORCE LEADER:

Jonathan P Singer, MD, MS
UC San Francisco
San Francisco, CA, USA

Dr. Jonathan Singer is a transplant pulmonologist and Assistant Professor of Medicine in the Division of Pulmonary, Critical Care, Allergy and Sleep Medicine at the University of California, San Francisco.  At UCSF, he is the Associate Medical Director of Lung Transplant Outcomes Research and is a core investigator with the UCSF Respiratory Epidemiology Group. His research focuses broadly on how lung transplantation improves patient-centered outcomes including functioning, disability, health-related quality of life, and survival. An area of particular interest is how frailty and refined assessments of body composition impact patient-centered outcomes in lung transplant candidates and recipients.

Dr. Singer received his undergraduate degree from Stanford University and a Masters in Health and Medical Sciences from the School of Public Health at UC Berkeley. He moved to UCSF to complete his medical degree, residency in internal medicine, and fellowships in pulmonary, critical care, and lung transplantation.



LINKS NEWSLETTER LIAISON:

Jussi Tikkanen, MD, PhD
University Health Network
Toronto, ON, CANADA

Jussi Tikkanen is originally from Helsinki, Finland but currently works as a lung transplant physician in the Toronto Lung Transplant Program. His research interests include donor-specific antibodies, primary graft dysfunction, and chronic lung allograft dysfunction.

LIAISONS TO OTHER COUNCILS:

BSTR COUNCIL LIAISON:

Pablo G. Sanchez, MD, PhD (2020)
University of Pittsburgh
Pittsburgh, PA, USA

Pablo G Sanchez, MD PhD, is a Lung Transplant Surgeon. He is the  Associate Director of Lung Transplant and the Adult ECLS program and the Director of Ex vivo Lung Perfusion and Lung Transplant Research at the University of Pittsbugh. He obtained his MD from the University of Cordoba, Argentina in 1999. Residency and Thoracic Surgery fellowship was obtained at the Santa Casa de Misericordia, Porto Alegre, Brazil. He also completed a research fellowship at the University of Pennsylvania, and a Post Doc fellowship at the University of Maryland. He is a national co-investigator for the NOVEL trial, evaluating the use of ex vivo perfusion to increase lung donor use. He received the F. Griffith Pearson Fellowship from The American Association for Thoracic Surgery. He has also received funding from the Maryland Stem Cell Research Foundation, the ISHLT research fellowship award and the University of Maryland and Living Legacy Foundation Transplantation Grant Program Award.


JFTC COUNCIL LIAISON:

Joshua J Mooney, MD (2019)
Stanford University
Stanford, CA, USA

Dr. Joshua Mooney is a Clinical Assistant Professor at Stanford University who specializes in the care of interstitial lung disease and lung transplant patients. He received his medical degree at University of Minnesota and then completed Internal Medicine residency at the University of California San Francisco followed by Pulmonary and Critical Care Fellowship and a Masters degree in Health Services Research at Stanford University. He performs health services and outcomes research focused on improving the lives and care of patients with advanced lung disease and is actively involved in clinical trials to improve outcomes in interstitial lung disease.


NHSAH COUNCIL LIAISON:

Nicole Davis, BSN, MPH, CCTC
Tampa General Hospital
Tampa, FL, USA

Nicole Davis has been a lung transplant coordinator at Tampa General Hospital for the past 3 years. Prior to that she worked as a transplant nurse clinician for 5 years. She received her BSN and MPH from East Carolina University. Her focus is currently on process improvement within the pre and post lung transplant clinics at Tampa General Hospital.

Text SizeIncrease Font SizeDecrease Font Size